Pulmonary Vascular Changes in Patients With Chronic Myeloid Leukemia With Second-line Therapy Dasatinib vs. Nilotinib
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dasatinib; Nilotinib
- Indications Chronic myeloid leukaemia
- Focus Pharmacodynamics
- 09 Sep 2015 Biomarkers information updated
- 12 Aug 2013 Planned End Date changed from 1 Jul 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 15 Mar 2013 New trial record